Tradestie Institutional Equity Comparison Engine

SBRA vs DEA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SBRA Overall Edge

SBRA Captures Institutional Edge (3โ€“1 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Sabra Healthcare REIT, Inc. (SBRA) driven by superior Valuation, Growth & Margin, Momentum & Technical while DEA counters with relative strength in Options & Structure. Fundamentally, SBRA trades at 30.4x Forward P/E with 18.4% operating margin (+31.6% YoY revenue) versus DEA at 46.1x Forward P/E and 25.2% operating margin (+8.8% YoY). In options structure, SBRA sits in CONSOLIDATION (17th %ile IV; Dealer Gamma Walls on Pro) against DEA sits in CONSOLIDATION (8th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner SBRA
SBRA 30.4x vs DEA 46.1x Fwd P/E
Growth & Margin Winner SBRA
Op Margin 18.4% vs 25.2% ยท YoY +31.6% vs +8.8%
Momentum & Technical Winner SBRA
1Y +8.7% vs +0.8% ยท 52W Pos 52% vs 22%
Options & Structure Winner DEA
CONSOLIDATION (17th %ile IV) vs CONSOLIDATION (8th %ile IV)
SBRA NASDAQ
Sabra Healthcare REIT, Inc.
Real Estate Investment Trusts
$20.27
-0.37% 1D
Market Cap $5.4B
1M Return +6.26%
1Y Return +8.71%
Forward P/E 30.4x
Unified AI Score
57.4 / 100 HOLD
Tech 49.0 Fund 57.0 Flow 57.0 Mom 64.0
DEA NYSE
Easterly Government Properties, Inc.
Real Estate Investment Trusts
$21.76
-0.59% 1D
Market Cap $1.1B
1M Return +1.35%
1Y Return +0.79%
Forward P/E 46.1x
Unified AI Score
45.1 / 100 HOLD
Tech 42.0 Fund 52.0 Flow 57.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SBRA +8.71% DEA +0.79% Spread: +7.92 pp (SBRA Lead)

Pillar 3 Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period SBRA Revenue DEA Revenue SBRA Op. Margin DEA Op. Margin Margin Edge
Q3 '25 $760M $340M 31.3% 25.0% SBRA
Q4 '25 $850M $350M 30.5% 25.0% SBRA
Q1 '26 $890M $370M 30.8% 22.5% SBRA
Q2 '26 $940M $370M -13.6% 24.4% DEA
Q3 '26 $1.00B $370M 25.6% 26.0% DEA

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SBRA (8) vs DEA (2)
Institutional Metric SBRA DEA Criterion Row Winner
Market Capitalization Scale $5.4B $1.1B Larger Scale SBRA
Trailing P/E Ratio Valuation 75.7x 76.1x Lower Multiple SBRA
Forward P/E Ratio Valuation 30.4x 46.1x Lower Multiple SBRA
Revenue Growth (YoY) Growth +31.6% +8.8% Higher Growth SBRA
Operating Margin (TTM) Profitability 18.4% 25.2% Higher Margin DEA
Net Profit Margin Profitability 7.7% 3.9% Higher Margin SBRA
Return on Equity (ROE) Capital Efficiency 2.5% 1.1% Higher ROE SBRA
52-Week Range Position Momentum 52% ($18โ€“$23) 22% ($21โ€“$26) Stronger Trend SBRA
Beta / 30D Volatility Risk Regime 0.00ฮฒ ยท 30% Vol 0.31ฮฒ ยท 26% Vol Lower Realized Risk DEA
Unified Institutional Score Composite Signal 57.4 / 100 (HOLD) 45.1 / 100 (HOLD) Higher Composite SBRA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SBRA vs DEA Buy Guide
SBRA CONSOLIDATION
80d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 17th %ile
IV Regime Compressed (<25th %ile)
Live SBRA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
DEA CONSOLIDATION
100d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 8th %ile
IV Regime Compressed (<25th %ile)
Live DEA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SBRA nor DEA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.